Drugs / Hantavax
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02553837 | Nov 2015 → Aug 2017 | — | Green Cross Corporation | Unknown | No outcome recorded |
| Phase 3 | NCT02360514 | Dec 2007 → Oct 2012 | infectious disease | Green Cross Corporation | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hantavax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02360514 ↗ |
| Known as | Hantavax injection | “Biological: Hantavax injection” NCT02553837 ↗ |
| Modality | Vaccine | “hantaan virus vaccine” NCT02360514 ↗ |
| Route | Intramuscular | “Intramuscular or hypodermic injection” NCT02360514 ↗ |